3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
3
Pancreatic Neoplasms
2
Pain, Postoperative
2
Neoplasms
2
Melanoma
2
Warts
1
Surgical Wound
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Neoplasms, Fibrous Tissue
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms, Connective Tissue
1
Neoplasms by Histologic Type
1
Myoma
1
Musculoskeletal Diseases
1
Meningioma
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Locally Advanced Cervical Cancer
1
Leiomyoma
1
Joint Diseases
1
Hemorrhage
1
Hematologic Neoplasms
1
Fibroma
1
Esophageal Neoplasms
1
Dupuytren Contracture
1
Contracture
1
Connective Tissue Diseases
1
Chronic Pain
1
Brain Neoplasms
1
Interventions
Cisplatin
2
zimberelimab
1
piperine
1
Sodium Chloride
1
Paclitaxel
1
Gemcitabine
1
Curcumin
1
Chemoradiotherapy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Locally Advanced Cervical Cancer
×
Sodium Chloride
×
Clear all
NCT06079671
2026-05-27
eVOLVECervical
AstraZeneca
Phase 3
Recruiting
800 enrolled